Neutrophil-lymphocyte ratio: a novel predictor of clinical outcome of patients with hepatocellular carcinoma / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 649-652, 2016.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-778595
Biblioteca responsável:
WPRO
ABSTRACT
Accumulating evidence has shown that neutrophil-lymphocyte ratio (NLR), as an assessment index for inflammatory response, is closely related to the prognosis of various malignant tumors. This article summarizes the research advances in the relationship of NLR with overall survival, disease-free survival, and pathological features of hepatocellular carcinoma and related mechanisms of action, and points out that NLR is a convenient, economic, and effective predictor for the prognosis of patients with hepatocellular carcinoma.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Estudo prognóstico
Idioma:
Chinês
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2016
Tipo de documento:
Artigo